⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
UTHR News
United Therapeutics Corp
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
businesswire.com
UTHR
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP ® for Treatment of Acute Liver Failure
businesswire.com
UTHR
Pulmonary Fibrosis Foundation Announces 2026 PFF Walk Season
prnewswire.com
CVS
LQDA
UTHR
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate
globenewswire.com
UTHR
PFE
AMGN
JNJ
ABBV
MRK
BMY
MAC
Maryland Businesses Announce Breakthrough Technologies, Portfolio Expansions and Customer Relief
prnewswire.com
EXC
DG
UTHR
Form 8-K
sec.gov
UTHR
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso ® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
businesswire.com
UTHR
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
businesswire.com
UTHR
Form 8-K
sec.gov
UTHR
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
businesswire.com
UTHR